Skip to content
Use caution Drug recall · FDA · Published December 23, 2013

Hospira Lidocaine Injection Recall: Particulate Matter Hazard

Hospira recalls 2% Lidocaine HCl Injection vials due to confirmed particulate matter in glass containers. This could cause contamination and health risks if injected.

🇺🇸 FDA recall #D-1278-2014DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer

Hospira is recalling 2% Lidocaine HCl Injection vials that contain particulate matter. This risk could lead to contamination if the medication is injected, potentially causing health issues. Read more at govinfonow.com/recall/46348-hospira-lidocaine-injection-recall-particulate-matter-hazard.

Source Summary by GovInfoNow · govinfonow.com/recall/46348-hospira-lidocaine-injection-recall-particulate-matter-hazard · Updated August 20, 2026 · FDA enforcement record: FDA #D-1278-2014

Cite this page

“Hospira Lidocaine Injection Recall: Particulate Matter Hazard.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/46348-hospira-lidocaine-injection-recall-particulate-matter-hazard. Based on FDA recall #D-1278-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1278-2014%22&limit=1).

The FDA announced on December 23, 2013, that Hospira Inc. voluntarily recalled Lidocaine HCl Injection due to the presence of particulate matter. The recall affects 68,350 vials distributed nationwide.

How to tell if you have it

  • Brand: Hospira
  • Product: Lidocaine HCl Injection, USP, 2%, 20 mg per mL
  • Packaging: 5-mL single-dose vials, 10 vials per box
  • NDC: 0409-2066-05
  • Lot Code: 32135DD
  • Expiration Date: 08/15
  • Quantity: 68,350 vials

The hazard

The recall was initiated following a confirmed customer complaint of particulates embedded in the glass container and in contact with the product solution. The FDA classified this as a Class I recall.

Context

GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include Asclemed Lidocaine HCl Injection Recall (June 8, 2026), American Regent Papaverine HCl Injection Recall (July 24, 2026), and Fresenius Kabi Lidocaine HCl Injection Recall (July 16, 2026).

How to tell if you have this one

Check for vials labeled 'Lidocaine HCl Injection, USP, 2%, 20 mg per mL, 5-mL single-dose vials, 10 per box' from Hospira. The lot number 32135DD and expiration date 08/15 are key identifiers.

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the product label includes 'Lidocaine HCl Injection, USP, 2%, 20 mg per mL, 5-mL single-dose vials, 10 per box' from Hospira.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Dec 23, 201312. FDA classified it Class I: Apr 27, 201423. Published in FDA’s Enforcement Report: May 7, 201434. FDA terminated the recall: Oct 7, 2014420132014
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1278-2014 (December 23, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1278-2014 to see it in context.
  • Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA